You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
新華製藥(000756.SZ)披露業績快報 2019年淨利升17.54%至3億元
格隆匯 01-13 17:19

格隆匯1月13日丨新華製藥(000756.SZ)披露2019年度業績快報,實現營業總收入56.07億元,同比增長6.92%;利潤總額3.82億元,同比增長15.00%;歸屬於上市公司股東的淨利潤3.00億元,同比增長17.54%;基本每股收益0.48元。

2019年集團努力克服市場競爭激烈等諸多因素影響,強化科技進步,加快新舊動能轉換和項目建設,狠抓市場開發,注重產品結構調整,生產經營繼續保持了良好發展態勢。截至2019年年末,歸屬於上市公司股東的所有者權益人民幣29.69億元,比年初增長10.15%。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account